0 XP 0   0   0  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Esperion Therapeutics Inc - Trending symbols

Latest News of Esperion Therapeutics Inc

DateTitleRead
2025-11-06
22:30
Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)Read



Trends

 2024-06-302024-09-302024-12-312025-03-312025-06-30
EBIT -48,20233,760-14,4429,546-4,896-16,128-21,02436,74515,721
EBITDA -48,19233,776-14,4169,547-4,869-16,129-20,99836,69315,695
Depreciation and Amortization 101626127-126-52-26
Other Current Assets 10,9753,93714,9123,69218,6044,92523,529-245,741-222,212
Income before Tax -61,71911,784-49,9358,685-41,250-15,094-56,344117,36661,022
Net Income -89,22039,285-49,9358,685-41,250-15,094-56,344117,36661,022
Operating Income -48,60511,547-37,0589,525-27,533-14,834-42,367114,63672,269
Net Income from Continuing Operations -61,71911,784-49,9358,685-41,250-15,094-56,344117,36661,022
Interest Expense 14,266-11314,15317614,3295814,387-28,924-14,537
Income Tax Expense 13,948-45413,494-52012,97414,52727,501-27,552-51
Other Stockholders Equity 909,4034,867914,270-914,038232990,238990,470-990,543-73
Long-term Assets Other 6,030-1,1784,852-5914,26145,73950,000-50,441-441

Comments

How you think about this?

Leave a comment

Stay informed about Esperion Therapeutics Inc.

Receive notifications about Esperion Therapeutics Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.